Back to SO Squarepoint Ops LLC

JANXJANX
Showing 8 of 14 quarters

Position history for SOSquarepoint Ops LLC's holdings in JANUX THERAPEUTICS INC

Squarepoint Ops LLC holds 532,321 shares of JANX (JANUX THERAPEUTICS INC), worth $8.2M as of 2026-Q2. The position was decreased (-11.9% shares). JANX represents 0.0% of Squarepoint Ops LLC's portfolio.

Current Value

$8.2M

Current Shares

532,321

Total Value Change

+$7.4M

Total Shares Change

+516,179

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
532,321
-11.9%
$8.2M0.0%$15.36
0
2026-Q1
Increased
604,000
+54.5%
$8.4M0.0%$13.44
39
2025-Q4
Increased
390,952
+490.9%
$5.4M0.0%$13.83
44
2025-Q3
Decreased
66,161
-65.1%
$1.6M0.0%$23.70
0
2025-Q2
Increased
189,569
+230.0%
$4.4M0.0%$23.15
43
2025-Q1
Increased
57,448
+39.5%
$1.6M0.0%$29.10
34
2024-Q4
Increased
41,176
+155.1%
$2.2M0.0%$52.50
42
2024-Q3
Decreased
16,142
-50.9%
$733,3310.0%$46.25
0

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used